[HTML][HTML] HPV vaccination crisis in Japan

SJB Hanley, E Yoshioka, Y Ito, R Kishi - The Lancet, 2015 - thelancet.com
Free vaccination against the human papillomavirus (HPV) began in December, 2010, for
Japanese girls aged 12–16 years and since April, 2013, the vaccine was included in the …

Japan resumes active recommendations of HPV vaccine after 8· 5 years of suspension

R Haruyama, H Obara, N Fujita - The lancet oncology, 2022 - thelancet.com
On Nov 26, 2021, the Ministry of Health, Labour, and Welfare of Japan officially issued an
announcement to resume active recommendations of the human papillomavirus (HPV) …

HPV vaccination programme in Japan

S Gilmour, M Kanda, E Kusumi, T Tanimoto, M Kami… - The lancet, 2013 - thelancet.com
The Japanese Ministry of Health, Labour, and Welfare (MHLW) partially suspended the
human papillomavirus (HPV) vaccination programme in June, 2013. Although HPV …

Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan

S Nakagawa, Y Ueda, A Yagi, S Ikeda… - Cancer …, 2020 - Wiley Online Library
In Japan, the serious adverse events after human papillomavirus (HPV) vaccination were
widely reported in the media. The Ministry of Health, Labour and Welfare of Japan (MHLW) …

[HTML][HTML] No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study

S Suzuki, A Hosono - Papillomavirus Research, 2018 - Elsevier
Nagoya City introduced free HPV vaccination in 2010 and in April 2013 the Ministry of
Health, Labour and Welfare included the HPV vaccine in the National Immunization …

[HTML][HTML] The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental …

A Yagi, Y Ueda, S Ikeda, E Miyagi, M Sekine… - The Lancet Regional …, 2022 - thelancet.com
565-0871, Japan bCenter for Cancer Control and Information Services, National Cancer
Center, Tokyo, Japan cDepartment of Obstetrics and Gynecology, Yokohama City University …

Present status of human papillomavirus vaccine development and implementation

R Herrero, P González, LE Markowitz - The Lancet Oncology, 2015 - thelancet.com
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts

R Sankaranarayanan, P Basu, P Kaur… - The Lancet …, 2019 - thelancet.com
Efforts are being made to scale up human papillomavirus (HPV) vaccination for adolescent
girls in India. Bivalent and quadrivalent HPV vaccines were licensed in the country in 2008 …

[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study

KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet Public …, 2020 - thelancet.com
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …

Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma

E Colzani, K Johansen, H Johnson… - …, 2021 - eurosurveillance.org
While many European Union/European Economic Area (EU/EEA) countries recently
expanded human papillomavirus (HPV) vaccination to boys, HPV vaccine supply is currently …